|
ZNF192 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.707900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.814000E-01 |
| Normal-vs-Stage2 |
4.939400E-01 |
| Normal-vs-Stage3 |
3.000400E-04 |
| Normal-vs-Stage4 |
6.03379999999376E-05 |
| Stage1-vs-Stage2 |
4.918800E-01 |
| Stage1-vs-Stage3 |
2.210700E-04 |
| Stage1-vs-Stage4 |
8.44300000000242E-05 |
| Stage2-vs-Stage3 |
9.929900E-02 |
| Stage2-vs-Stage4 |
3.929900E-02 |
| Stage3-vs-Stage4 |
4.895800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.323900E-02 |
| Normal-vs-AfricanAmerican |
2.682300E-02 |
| Normal-vs-Asian |
8.165400E-01 |
| Caucasian-vs-AfricanAmerican |
1.882410E-01 |
| Caucasian-vs-Asian |
4.268600E-01 |
| AfricanAmerican-vs-Asian |
2.602600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.175100E-03 |
| Normal-vs-Female |
3.254600E-01 |
| Male-vs-Female |
1.129230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.328000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.732400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.440800E-03 |
| Normal-vs-Age(81-100Yrs) |
5.409900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.104600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.707800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.270200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.010100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.211400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.646000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.239800E-02 |
| Normal-vs-Grade 2 |
7.836200E-01 |
| Normal-vs-Grade 3 |
1.663440E-03 |
| Normal-vs-Grade 4 |
7.2480999979696E-08 |
| Grade 1-vs-Grade 2 |
9.681900E-02 |
| Grade 1-vs-Grade 3 |
8.020500E-04 |
| Grade 1-vs-Grade 4 |
3.07119999998218E-06 |
| Grade 2-vs-Grade 3 |
3.026400E-04 |
| Grade 2-vs-Grade 4 |
8.31049995486666E-09 |
| Grade 3-vs-Grade 4 |
2.143400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.836640E-01 |
| Normal-vs-ccB subtype |
2.298200E-03 |
| ccA subtype-vs-ccB subtype |
3.59059999999189E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.032600E-01 |
| Normal-vs-N1 |
6.200100E-02 |
| N0-vs-N1 |
1.078820E-01 |
|
|
